DiRx Inc., a Monroe, NJ-based digital health company, closed a $5m seed funding round.
Backers included healthcare-specialized US investors.
The company intends to use the funds to enable readiness of its HIPAA-compliant virtual pharmacy platform, and to scale-up its pre-launch activities.
Led by Satish Srinivasan, Founder and CEO, DiRx is a digital health company seeking to provide U.S. consumers with direct access to generic Rx (prescription) medications through a cash-based subscription pharmacy model.
When the company launches its service, currently anticipated in Spring 2021, consumers across all the 50 states will be able to order their prescription generic medication using the DiRx App and/or website from their home, connect with a pharmacist as needed, and get in-home delivery and refills.
The service will be available on a cash-only subscription basis, without insurance.